DarioHealth Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, DarioHealth stock has a consensus rating of "Buy" and an average price target of $18.5. The average 1-year stock price forecast is 163.91% higher than the current stock price, while the lowest is $10 (+42.65%) and the highest is $28 (+299.43%).

Price Target: $18.5 (+163.91%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$10	$18.5	$18	$28
Change	+42.65%	+163.91%	+156.78%	+299.43%

* Price targets were last updated on May 15, 2026.

Analyst Ratings

The average analyst rating for DarioHealth stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Nov '25	Jan '26	Mar '26	Apr '26	May '26
Strong Buy	3	3	3	4	3	3
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	5	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Grossman Stifel Nicolaus	Stifel Nicolaus	Buy Maintains $10	Buy	Maintains	$10	+42.65%	May 15, 2026
Charles Rhyee TD Cowen	TD Cowen	Hold Maintains $11	Hold	Maintains	$11	+56.92%	May 13, 2026

Financial Forecast

Revenue This Year

26.16M

from 22.36M

17.00%

from 22.36M

Revenue Next Year

38.23M

from 26.16M

46.13%

from 26.16M

EPS This Year

-2.81

from -7.33

EPS Next Year

-0.68

from -2.81

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	20.51M	27.66M	20.35M	27.04M	22.36M	26.16M
Revenue Growth	170.76%	34.82%	-26.41%	32.86%	-17.31%	17.00%
Gross Profit	8.07M	14.01M	10.37M	18.30M	14.34M	15.70M
Gross Margin	39.34%	50.67%	50.95%	67.66%	64.11%	60.03%
Operating Income	-74.47M	-56.81M	-56.06M	-57.02M	-36.66M	-26.23M
Net Income	-76.76M	-62.19M	-59.43M	-42.75M	-41.71M	-30.32M
EPS	-	-	-	-	-7.33	-2.81
Free Cash Flow	-14.25M	-26.26M	-7.44M	-11.83M	-11.20M	-15.60M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	27.0M
Avg	26.2M
Low	25.5M

Revenue Growth

Revenue Growth	2026	2027	2028
High	20.8%
Avg	17.0%
Low	13.9%

EPS Forecast

EPS	2026	2027	2028
High	-2.76
Avg	-2.81
Low	-2.86

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-